HomeNewsOpinionCOVID-19 | Little legroom for a big stimulus

COVID-19 | Little legroom for a big stimulus

While the need for a large fiscal stimulus is paramount, its prospects should be examined taking into consideration the scope for financing a large fiscal deficit.

April 17, 2020 / 16:42 IST
Story continues below Advertisement
Representative Image
Representative Image

DK Srivastava

The COVID-19 pandemic has already damaged global and Indian growth prospects for 2020-21 to an extent which is likely to be worse than the 2008-09 global economic and financial crisis.

Story continues below Advertisement

Growth Contraction And Economic Slowdown

In 2009, the global economy witnessed a contraction of (-) 0.1 percent. Many of the developed economies, such as the United States (-2.5 percent), Germany (-5.7 percent) and Japan (-5.4 percent) witnessed deeper contraction. Many multilateral institutions, rating agencies and think-tanks indicate that the impact of COVID-19 will force the world economy into a comparatively deeper recession. For example, Fitch, JP Morgan and the United Nations (lower estimate) project the global growth in 2020 to contract by (-) 1.9 percent, (-) 1.1 percent and (-) 0.9 percent respectively.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show